Condition
Urinary Bladder Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Urinary Bladder Cancer clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (2), Italy (1)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Urinary Bladder Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sequential gemcitabine plus Jelmyto for favorable high-grade upper tract urothelial cancer | Phase 2 | New Brunswick, New Jersey | Recruiting | Feb 12, 2025 |
| Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues | Phase 2 | Orange, California | Recruiting | Aug 30, 2024 |
| Personalizing cancer therapy by measuring immune suppression | — | Milan | Recruiting | Nov 18, 2022 |
| Using Pembrolizumab after Tri-modality Treatment for Muscle-invasive Bladder Cancer | Phase 2 | Beijing, Beijing Municipality | Recruiting | Oct 11, 2021 |
| Neoadjuvant treatment for advanced bladder cancer using Toripalimab with chemotherapy | Phase 2 | Guangzhou, Guangdong | Recruiting | Apr 27, 2021 |
| Evaluating urine tests for detecting bladder cancer | — | Burlington, Massachusetts | Recruiting | Mar 31, 2009 |
All recruiting trials (6)
-
Sequential gemcitabine plus Jelmyto for favorable high-grade upper tract urothelial cancer
This trial tests whether giving gemcitabine followed by Jelmyto directly into the kidney can control favorable high‑grade upper tract urothelial cancer and help people avoid kidney removal.
-
Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues
This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.
-
Personalizing cancer therapy by measuring immune suppression
This study is testing whether measuring certain immune cells in cancer patients can help tailor their treatments and understand how feelings of isolation might affect their immune system.
-
Using Pembrolizumab after Tri-modality Treatment for Muscle-invasive Bladder Cancer
This study is testing if the drug pembrolizumab can help people with muscle-invasive bladder cancer stay cancer-free after they’ve had surgery and other treatments.
-
Neoadjuvant treatment for advanced bladder cancer using Toripalimab with chemotherapy
This study is testing if a new treatment combining Toripalimab with chemotherapy can help people with advanced bladder cancer before they have surgery.
-
Evaluating urine tests for detecting bladder cancer
This study is testing if urine tests that look for DNA and proteins can help detect bladder and kidney cancers in patients undergoing treatment or with a history of the disease.
Related topics
Quick answers
How many Urinary Bladder Cancer clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.